Global Chronic Heart Failure Market Entry Strategies

1
Chronic Heart Failure - Pipeline Review, H1 2014
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published February 2014
• Single User PDF US 2000
• Corporate User PDF US 6000

2
Chronic Heart Failure - Pipeline Review, H1 2014

• Chronic Heart Failure - Pipeline Review, H1 2014,
  provides an overview of the Chronic Heart
  Failures therapeutic pipeline.
• This report provides comprehensive information on
  the therapeutic development for Chronic Heart
  Failure Market, complete with comparative
  analysis at various stages, therapeutics
  assessment by drug target, mechanism of action
  (MoA), route of administration (RoA) and molecule
  type, along with latest updates, and featured
  news and press releases. It also reviews key
  players involved in the therapeutic development
  for Chronic Heart Failure and special features on
  late-stage and discontinued projects..
• The report features investigational drugs from
  across globe covering over 20 therapy areas and
  nearly 3,000 indications. The report is built
  using data and information sourced from
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources.
  Drug profiles/records featured in the report
  undergoes periodic updation following a stringent
  set of processes that ensures that all the
  profiles are updated with the latest set of
  information. Additionally, processes including
  live news deals tracking, browser based
  alert-box and clinical trials registries tracking
  ensure that the most recent developments are
  captured on a real time basis.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Chronic Heart Failure - Pipeline Review, H1 2014

• The report enhances decision making capabilities
  and help to create effective counter strategies
  to gain competitive advantage. It strengthens RD
  pipelines by identifying new targets and MOAs to
  produce first-in-class and best-in-class
  products.
• Scope- The report provides a snapshot of the
  global therapeutic landscape of Chronic Heart
  Failure- The report reviews key pipeline
  products under drug profile section which
  includes, product description, MoA and RD brief,
  licensing and collaboration details other
  developmental activities - The report reviews
  key players involved in the therapeutics
  development for Chronic Heart Failure and enlists
  all their major and minor projects- The report
  summarizes all the dormant and discontinued
  pipeline projects  
• A review of the Chronic Heart Failure products
  under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources- Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages- A detailed assessment of
  monotherapy and combination therapy pipeline
  projects- Coverage of the Chronic Heart Failure
  pipeline on the basis of target, MoA, route of
  administration and molecule type- Latest news
  and deals relating related to pipeline products
• Buy a copy of report _at_ http//www.reportsnreports.
  com/Purchase.aspx?name280051.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Chronic Heart Failure - Pipeline Review, H1 2014

• Reasons to buy- Provides strategically
  significant competitor information, analysis, and
  insights to formulate effective RD development
  strategies- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage- Develop strategic initiatives by
  understanding the focus areas of leading
  companies- Identify and understand important and
  diverse types of therapeutics under development
  for Chronic Heart Failure- Plan mergers and
  acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Chronic Heart Failure pipeline
  depth and focus of Indication therapeutics-
  Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and scope- Modify the
  therapeutic portfolio by identifying discontinued
  projects and understanding the factors that drove
  them from pipeline
• Inquire for Discount _at_ http//www.reportsnreports.
  com/contacts/Discount.aspx?name280051.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Chronic Heart Failure - Pipeline Review, H1 2014

• List of Tables
• Number of Products under Development for Chronic
  Heart Failure, H1 2014 11Number of Products
  under Development for Chronic Heart Failure -
  Comparative Analysis, H1 2014 12Number of
  Products under Development by Companies, H1 2014
  14Number of Products under Development by
  Companies, H1 2014 (Contd..1) 15Number of
  Products under Investigation by
  Universities/Institutes, H1 2014 16Comparative
  Analysis by Late Stage Development, H1 2014
  17Comparative Analysis by Clinical Stage
  Development, H1 2014 18 
• Comparative Analysis by Early Stage Development,
  H1 2014 19Comparative Analysis by Unknown Stage
  Development, H1 2014 20Products under
  Development by Companies, H1 2014 21Products
  under Investigation by Universities/Institutes,
  H1 2014 22Chronic Heart Failure - Pipeline by
  Hospira, Inc., H1 2014 23Chronic Heart Failure -
  Pipeline by Sanofi, H1 2014 24Chronic Heart
  Failure - Pipeline by Novartis AG, H1 2014
  25Chronic Heart Failure - Pipeline by
  Laboratoires Pierre Fabre SA, H1 2014 26Chronic
  Heart Failure - Pipeline by Les Laboratoires
  Servier SAS, H1 2014 27Chronic Heart Failure -
  Pipeline by Pfizer Inc., H1 2014 28 Chronic
  Heart Failure - Pipeline by Bayer AG, H1 2014
  29Chronic Heart Failure - Pipeline by Celladon
  Corporation, H1 2014 30Chronic Heart Failure -
  Pipeline by Mesoblast Limited, H1 2014 31Chronic
  Heart Failure - Pipeline by Palatin Technologies,
  Inc., H1 2014 32Chronic Heart Failure - Pipeline
  by MetrioPharm AG, H1 2014 33

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
Chronic Heart Failure - Pipeline Review, H1 2014

• List of Tables(Cont..)
• Chronic Heart Failure - Pipeline by Scynexis,
  Inc., H1 2014 34Chronic Heart Failure - Pipeline
  by t2cure GmbH, H1 2014 35Chronic Heart Failure
  - Pipeline by Cyano Biotech GmbH, H1 2014
  36Chronic Heart Failure - Pipeline by NormOxys,
  Inc., H1 2014 37Chronic Heart Failure - Pipeline
  by Cardioxyl Pharmaceuticals, Inc., H1 2014
  38Chronic Heart Failure - Pipeline by PhaseBio
  Pharmaceuticals, Inc., H1 2014 39Chronic Heart
  Failure - Pipeline by miRagen Therapeutics, Inc.,
  H1 2014 40Chronic Heart Failure - Pipeline by
  Fibrotech Therapeutics Pty. Ltd., H1 2014 41
• Chronic Heart Failure - Pipeline by Otsuka
  Holdings Co., Ltd., H1 2014 42Chronic Heart
  Failure - Pipeline by Provasculon, Inc., H1 2014
  43Chronic Heart Failure - Pipeline by Zensun
  (Shanghai) Sci Tech Co., Ltd., H1 2014
  44Assessment by Monotherapy Products, H1 2014
  45Assessment by Combination Products, H1 2014
  46Number of Products by Stage and Target, H1
  2014 49Number of Products by Stage and Mechanism
  of Action, H1 2014 52Number of Products by Stage
  and Route of Administration, H1 2014 54Number of
  Products by Stage and Molecule Type, H1 2014
  56Chronic Heart Failure Therapeutics - Recent
  Pipeline Updates, H1 2014 103Chronic Heart
  Failure - Dormant Projects, H1 2014 127
• List of Figures
• Number of Products under Development for Chronic
  Heart Failure, H1 2014 11Number of Products
  under Development for Chronic Heart Failure -
  Comparative Analysis, H1 2014 12Number of
  Products under Development by Companies, H1 2014
  13

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
7
Chronic Heart Failure - Pipeline Review, H1 2014

• List of Figures(Cont..)
• Comparative Analysis by Late Stage Development,
  H1 2014 17Comparative Analysis by Clinical Stage
  Development, H1 2014 18Comparative Analysis by
  Early Stage Products, H1 2014 19Assessment by
  Monotherapy Products, H1 2014 45Number of
  Products by Top 10 Target, H1 2014 47Number of
  Products by Stage and Top 10 Target, H1 2014
  48Number of Products by Top 10 Mechanism of
  Action, H1 2014 50Number of Products by Stage
  and Top 10 Mechanism of Action, H1 2014 51Number
  of Products by Top 10 Route of Administration, H1
  2014 53Number of Products by Stage and Top 10
  Route of Administration, H1 2014 54Number of
  Products by Top 10 Molecule Type, H1 2014
  55Number of Products by Stage and Top 10
  Molecule Type, H1 2014 56
• Explore Report on Pharmaceuticals Therapeutic
  Market.
• Contact sales_at_reportsandreports.com / Call 1 888
  391 5441 for further information on Chronic
  Heart Failure - Pipeline Review, H1 2014 report
  OR for any other market research and intelligence
  needs you may have for your business.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.